Gland Pharma Limited (NSE: GLAND)
India
· Delayed Price · Currency is INR
1,779.45
+14.65 (0.83%)
Dec 24, 2024, 3:30 PM IST
Gland Pharma Revenue
Gland Pharma had revenue of 14.06B INR in the quarter ending September 30, 2024, with 2.36% growth. This brings the company's revenue in the last twelve months to 58.90B, up 36.81% year-over-year. In the fiscal year ending March 31, 2024, Gland Pharma had annual revenue of 56.65B with 56.29% growth.
Revenue (ttm)
58.90B
Revenue Growth
+36.81%
P/S Ratio
4.98
Revenue / Employee
13.97M
Employees
4,217
Market Cap
293.17B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGland Pharma News
- 13 days ago - Gland Pharma stock jump 3% on USFDA approval for Phytonadione Injectable Emulsion - Business Upturn
- 14 days ago - Gland Pharma receives approval for Phytonadione Injectable Emulsion from US FDA - Business Upturn
- 22 days ago - Gland Pharma gets USFDA nod for Latanoprost Ophthalmic Solution - Business Upturn
- 4 weeks ago - T’gana pharma biggies to inject 5,200cr in Pharma City, create over 12,000 jobs - The Times of India
- 6 weeks ago - Gland Pharma stock jumps 10% this week after Q2 results - Business Upturn
- 7 weeks ago - Gland Pharma shares surge over 12% – Know More - Business Upturn
- 7 weeks ago - Gland Pharma shares jump 6% on Q2 FY25 results - Business Upturn
- 7 weeks ago - Gland Pharma share price: Goldman Sachs maintains sell call on Gland Pharma with target price of Rs 1,450, sees 10% downside - Business Upturn